Dovitinib

• Background :

  Dovitinib is a potent growth factor receptor kinase inhibitor with effects against FLT-3, c-KIT, VEGFR, PDGFRß and CSF-1R.

• Description :

  FGFR3 inhibitor

• Product Name Alternative :

  4-​​amino-​​5-​​fluoro-​​3-​​[6-​​ (4-​​methyl-​​1-​​piperazinyl) ​-​​1H-​​benzimidazol-​​2-​​yl]​-​2 (1H) ​-​​quinolinone

• UNSPSC :

  41116105

• Type :

  Inhibitor

• Source :

  Synthetic

• Field of Research :

  Cell Signaling

• Purity :

  ≥98%

• Weight :

  0.025

• Format :

  Crystalline solid

• Solubility :

  Soluble in DMSO

• Molecular Formula :

  C21H21FN6O

• Molecular Weight :

  392.4

• Precautions :

  Not for use in humans. Not for use in diagnostics or therapeutics. For in vitro research use only.

• References & Citations :

  1. Konecny G.E., et al. (2013) Mol. Cancer Ther. 12(5): 632–642.

• CAS Number :

  405169-16-6